FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews
In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF
NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget
FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available
DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation
DCE Technical Support Contracts Recompetition Approved in Concept
Trending Stories
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - An overlooked immune cell population may offer new direction for cell and gene therapy
- Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology